Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Recent Advances In SCF Ubiquitin Ligase Complex: Clinical Implications.

Nana Zheng, Q. Zhou, Z. Wang, W. Wei
Published 2016 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
F-box proteins, which are subunit recruiting modules of SCF (SKP1-Cullin 1-F-box protein) E3 ligase complexes, play critical roles in the development and progression of human malignancies through governing multiple cellular processes including cell proliferation, apoptosis, invasion and metastasis. Moreover, there are emerging studies that lead to the development of F-box proteins inhibitors with promising therapeutic potential. In this article, we describe how F-box proteins including but not restricted to well-established Fbw7, Skp2 and β-TRCP, are involved in tumorigenesis. However, in-depth investigation is required to further explore the mechanism and the physiological contribution of undetermined F-box proteins in carcinogenesis. Lastly, we suggest that targeting F-box proteins could possibly open new avenues for the treatment and prevention of human cancers.
This paper references
10.1038/jid.2013.281
A signal transduction pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma.
Xuan Qu (2014)
10.1016/j.cell.2012.03.043
Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair
Vincenzo D’Angiolella (2012)
10.1158/0008-5472.CAN-04-1626
Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
S. Müerköster (2005)
10.4317/medoral.18781
Immunohistochemical expression of Skp2 protein in oral nevi and melanoma
Bruno A. Benevenuto-de-Andrade (2013)
10.1126/SCIENCE.1141194
SCFFbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins
L. Busino (2007)
10.1038/onc.2010.584
Phosphorylation-dependent regulation of SCFFbx4 dimerization and activity involves a novel component, 14-3-3ε
O. Barbash (2011)
10.1038/labinvest.2009.138
Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou (2010)
10.1016/S1097-2765(04)00268-0
Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis.
M. Pagano (2004)
10.1074/jbc.M804340200
Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets c-Myb for Nemo-like Kinase (NLK)-induced Degradation*
C. Kanei-Ishii (2008)
10.1074/jbc.M509855200
The F-box Protein FBX4 Targets PIN2/TRF1 for Ubiquitin-mediated Degradation and Regulates Telomere Maintenance*
T. Lee (2006)
10.1038/nature04433
Histone demethylation by a family of JmjC domain-containing proteins
Y. Tsukada (2006)
10.1371/journal.pone.0047298
Targeting the Oncogenic E3 Ligase Skp2 in Prostate and Breast Cancer Cells with a Novel Energy Restriction-Mimetic Agent
Shuo Wei (2012)
10.1182/blood-2011-06-358911
F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.
B. Chen (2012)
10.1172/JCI22220
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
H. Li (2004)
10.1083/jcb.201209002
FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress
Yeon-Tae Jeong (2013)
10.1038/nature09732
SCFFbw7 Regulates Cellular Apoptosis By Targeting Mcl-1 for Ubiquitination and Destruction
H. Inuzuka (2011)
10.1002/gcc.10037
APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers
Amy V. Gerstein (2002)
10.1172/JCI15795
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
S. Signoretti (2002)
10.1210/en.2008-0408
EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
H. Huang (2008)
10.1038/onc.2008.77
Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy
S. Finkin (2008)
10.1126/SCIENCE.1065203
Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase
D. Koepp (2001)
10.1093/nar/gku876
FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response
Z. Chen (2014)
10.1016/j.molcel.2008.12.020
betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis.
E. Dehan (2009)
Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
T. Masuda (2002)
10.1182/blood-2007-09-112904
Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.
Q. Chen (2008)
10.1038/sj.emboj.7600217
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7
M. Yada (2004)
10.1016/j.ccr.2008.05.017
Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer.
O. Barbash (2008)
10.1093/emboj/19.6.1378
Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin–cyclin interaction
M. Kong (2000)
10.1007/s10555-011-9330-z
Role of the ubiquitin ligase Fbw7 in cancer progression
Y. Cheng (2011)
10.5732/cjc.010.10403
Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China
H. Xu (2011)
10.1042/BJ20140006
RBR E3 ubiquitin ligases: new structures, new insights, new questions
D. E. Spratt (2014)
10.1158/1535-7163.MCT-07-0104
p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells
S. Roy (2007)
10.1038/onc.2009.111
Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb
K. Kitagawa (2009)
10.1016/j.ijrobp.2008.04.008
Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients.
F. Fang (2009)
10.1016/J.CELREP.2012.04.002
SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.
H. Fukushima (2012)
10.1074/jbc.M112.426882
SCFFbxw15 Mediates Histone Acetyltransferase Binding to Origin Recognition Complex (HBO1) Ubiquitin-Proteasomal Degradation to Regulate Cell Proliferation*
C. Zou (2013)
10.1074/jbc.M413986200
FBW2 Targets GCMa to the Ubiquitin-Proteasome Degradation System*
Chih-Sheng Yang (2005)
10.1371/journal.pone.0037433
Cks1 Is Required for Tumor Cell Proliferation but Not Sufficient to Induce Hematopoietic Malignancies
S. Kratzat (2012)
10.1371/journal.pone.0059132
The F-Box Protein MEC-15 (FBXW9) Promotes Synaptic Transmission in GABAergic Motor Neurons in C. elegans
Y. Sun (2013)
10.1021/jf201096v
1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein.
H. Huang (2011)
10.1073/PNAS.0307875101
Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein.
M. Tetzlaff (2004)
10.1128/MCB.01665-07
Disruption of the Fbxw8 Gene Results in Pre- and Postnatal Growth Retardation in Mice
T. Tsutsumi (2007)
10.3892/IJO_00000841
SKP2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis.
S. Schüler (2011)
10.1074/jbc.M604311200
Constitutive and UV-induced Fibronectin Degradation Is a Ubiquitination-dependent Process Controlled by β-TrCP*
D. Ray (2006)
10.1038/sj.emboj.7600775
Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6
H. Laman (2005)
10.1074/jbc.M109.065995
The Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation*
R. Viñas-Castells (2009)
10.1038/onc.2012.235
GSK3-SCFFBXW7 targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase
B. Pérez-Benavente (2013)
10.1016/j.bbrc.2013.07.091
FBXW10 is negatively regulated in transcription and expression level by protein O-GlcNAcylation.
Z. Feng (2013)
10.1038/nrm3582
Mechanisms and function of substrate recruitment by F-box proteins
J. Skaar (2013)
10.1007/s12253-009-9171-z
The Expression and Prognosis of FOXO3a and Skp2 in Human Hepatocellular Carcinoma
Mu-dan Lu (2009)
10.1074/jbc.M312337200
Mouse Fbw7/Sel-10/Cdc4 Is Required for Notch Degradation during Vascular Development*
R. Tsunematsu (2004)
10.1186/1471-2121-3-22
The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells
L. Lu (2002)
10.1007/s00018-014-1665-5
The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE)
Jengmin Kang (2014)
10.1158/0008-5472.CAN-10-0040
The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
D. Zhao (2010)
10.1038/ncb1173
Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition
B. Zhou (2004)
10.1074/jbc.M205503200
Cyclin F Is Degraded during G2-M by Mechanisms Fundamentally Different from Other Cyclins*
T. K. Fung (2002)
10.1038/nrc2290
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker (2008)
10.1039/c5mb00166h
A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
X. Yu (2015)
10.1016/J.MOLCEL.2006.05.020
Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.
Frank van Drogen (2006)
10.1038/ncb3076
Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing
Julia K. Pagan (2015)
10.1158/0008-5472.CAN-09-2190
Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.
L. Fu (2009)
10.1158/1078-0432.CCR-04-1162
Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas
A. Koch (2005)
10.1073/pnas.1306358110
CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
T. Kim (2013)
10.1038/nature10688
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
Shanshan Duan (2011)
10.1007/s11033-010-0288-7
Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells
P. Lin (2010)
10.1073/pnas.1133216100
Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene
K. Nakayama (2003)
10.1182/blood-2007-09-113860
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.
Anupriya Agarwal (2008)
10.1016/J.MOLCEL.2006.09.007
Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex
D. I. Lin (2006)
10.1038/cdd.2010.185
F-box protein 10, an NF-κB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c-FLIP pathway
R. Ge (2011)
10.1038/embor.2011.231
Emerging roles of the FBW7 tumour suppressor in stem cell differentiation
Z. Wang (2011)
10.1038/25159
Identification of the receptor component of the IκBα–ubiquitin ligase
A. Yaron (1998)
10.1182/blood-2014-03-562694
Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
T. Ueda (2015)
10.1158/0008-5472.CAN-07-1320
FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Shahab Akhoondi (2007)
10.1126/SCIENCE.1092880
The Ubiquitin Ligase SCFFbw7 Antagonizes Apoptotic JNK Signaling
Abdolrahman S Nateri (2004)
10.1111/cas.12100
Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis
Jia Fu (2013)
10.1016/j.ajpath.2013.01.016
Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation.
Christopher Sistrunk (2013)
10.1101/GAD.1255304
Systematic analysis and nomenclature of mammalian F-box proteins.
J. Jin (2004)
10.1073/PNAS.0406789102
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.
H. Huang (2005)
10.4161/cc.24165
FBH1 protects melanocytes from transformation and is deregulated in melanomas
Yeon-Tae Jeong (2013)
10.3892/ol.2014.2031
FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma
J. Zhu (2014)
10.1074/jbc.M111.253807
The Fbw7 Tumor Suppressor Regulates Nuclear Factor E2-related Factor 1 Transcription Factor Turnover through Proteasome-mediated Proteolysis*
M. Biswas (2011)
10.1002/cbic.201200777
Computationally Designed Peptide Inhibitors of the Ubiquitin E3 Ligase SCFFbx4
J. Lee (2013)
10.1182/blood-2014-03-559542
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
M. J. Kiel (2014)
Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Eun-Hee Shim (2003)
10.1016/J.CMET.2005.04.010
Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7).
A. Sundqvist (2005)
10.1016/j.febslet.2012.03.017
Tumor suppressor functions of FBW7 in cancer development and progression
Z. Wang (2012)
10.1101/GAD.1157503
SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
J. Jin (2003)
10.1371/journal.pone.0017578
Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival
Guangdi Chen (2011)
10.1126/SCIENCE.1065874
Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy
S. Bodine (2001)
10.1186/1476-4598-13-76
F-box protein complex FBXL19 regulates TGFβ1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation
Su Dong (2014)
10.1074/JBC.M306340200
Vitamin D Inhibits G1 to S Progression in LNCaP Prostate Cancer Cells through p27Kip1 Stabilization and Cdk2 Mislocalization to the Cytoplasm*
E. Yang (2003)
10.1053/j.gastro.2010.05.078
F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
R. Sancho (2010)
10.1016/j.bbrc.2014.06.094
MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8.
Dazun Shi (2014)
10.1002/jcb.23321
Negative regulation of HIF‐1α by an FBW7‐mediated degradation pathway during hypoxia
J. Cassavaugh (2011)
10.1074/JBC.M301774200
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase*
G. Bornstein (2003)
10.1371/journal.pone.0052675
Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas
J. Liu (2012)
10.3892/or.2011.1369
SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells.
Ke-feng Lei (2011)
10.1038/ncb2731
FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade
S. Kuchay (2013)
10.1016/J.CCR.2005.06.005
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.
W. Wei (2005)
10.3892/or.2012.2065
Role of FBXL20 in human colorectal adenocarcinoma.
Jianjun Zhu (2012)
10.1100/tsw.2010.89
Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression
C. Chan (2010)
10.1038/nrc3700
Roles of F-box proteins in cancer
Z. Wang (2014)
10.1016/j.bbrc.2014.03.129
Alternative splicing variants of human Fbx4 disturb cyclin D1 proteolysis in human cancer.
Xiufeng Chu (2014)
10.1038/nature02082
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
L. Busino (2003)
10.1042/BJ20130175
RACK1 (receptor for activated C-kinase 1) interacts with FBW2 (F-box and WD-repeat domain-containing 2) to up-regulate GCM1 (glial cell missing 1) stability and placental cell migration and invasion.
Chang-chun Wang (2013)
10.1093/emboj/19.9.2069
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
K. Nakayama (2000)
10.1371/journal.pone.0016012
Nonsense Mediated Decay Resistant Mutations Are a Source of Expressed Mutant Proteins in Colon Cancer Cell Lines with Microsatellite Instability
D. Williams (2010)
10.1593/NEO.06568
SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
M. Tan (2006)
10.1111/j.1582-4934.2012.01524.x
Identification of F-box only protein 7 as a negative regulator of NF-kappaB signalling
H. Kuiken (2012)
10.1038/nrd3321
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
L. Bedford (2011)
10.1038/nature09779
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
I. Wertz (2011)
10.1038/onc.2015.291
Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation
W-h Yang (2016)
10.1016/j.devcel.2011.09.014
SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.
M. Tan (2011)
10.1038/onc.2013.471
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx)
R. Ciarapica (2014)
10.1016/j.cell.2011.09.019
Global Identification of Modular Cullin-RING Ligase Substrates
Michael J. Emanuele (2011)
10.1073/pnas.251541198
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
M. Gomes (2001)
10.1038/sj.onc.1208418
Overexpression of human βTrCP1 deleted of its F box induces tumorigenesis in transgenic mice
Nadia Belaïdouni (2005)
10.4161/cc.25622
The p27–Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells
M. Kullmann (2013)
10.1161/CIRCRESAHA.110.238717
Endogenous Muscle Atrophy F-Box Mediates Pressure Overload–Induced Cardiac Hypertrophy Through Regulation of Nuclear Factor-&kgr;B
S. Usui (2011)
10.1016/j.ccr.2013.09.021
Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors.
H. Zhao (2013)
10.1186/1747-1028-5-27
GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms
K. Kitagawa (2010)
10.1016/j.chembiol.2012.09.015
Specific small molecule inhibitors of Skp2-mediated p27 degradation.
L. Wu (2012)
10.1126/SCIENCE.1130276
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
N. Dorrello (2006)
10.1242/jcs.080465
Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells
El Kahina Meziane (2011)
10.1016/S0960-9822(99)80290-5
p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27
L. Tsvetkov (1999)
10.1159/000015532
Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors
D. S. Chiaur (2000)
10.1016/j.cell.2007.04.030
Circadian Mutant Overtime Reveals F-box Protein FBXL3 Regulation of Cryptochrome and Period Gene Expression
Sandra M. Siepka (2007)
Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice.
Y. A. Minamishima (2002)
10.1128/MCB.24.18.8184-8194.2004
Role of F-Box Protein βTrcp1 in Mammary Gland Development and Tumorigenesis
Y. Kudo (2004)
10.1038/embor.2010.2
Skp2B attenuates p53 function by inhibiting prohibitin
H. Chander (2010)
10.1371/journal.pone.0021165
Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis
M. Lomonosov (2011)
10.1038/nrd2056
Drug discovery in the ubiquitin–proteasome system
G. Nalepa (2006)
10.1158/0008-5472.CAN-06-0149
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
J. Hulit (2006)
10.1038/nature09140
SCFCyclin F controls centrosome homeostasis and mitotic fidelity via CP110 degradation
Vincenzo D’Angiolella (2010)
10.1074/jbc.M113.520106
The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1*
H. Wang (2013)
10.1021/pr2010204
Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.
Bin Liu (2012)
10.1002/cncr.28764
Aberrant methylation and decreased expression of the TGF‐β/Smad target gene FBXO32 in esophageal squamous cell carcinoma
W. Guo (2014)
10.1080/15384047.2015.1026512
FBXO4 loss facilitates carcinogen induced papilloma development in mice
Z. Lian (2015)
10.1074/jbc.M807641200
MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines*
Alfredo Csibi (2009)
10.4161/cbt.5.1.2290
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer
M. Koh (2006)
10.1677/ERC-09-0062
Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
T. van Agthoven (2010)
10.1038/cddis.2013.271
Skp-cullin-F box E3 ligase component FBXL2 ubiquitinates Aurora B to inhibit tumorigenesis
B. Chen (2013)
FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.
E. de la Chesnaye (2015)
10.1128/MCB.00620-06
Degradation of Mcl-1 by β-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization
Q. Ding (2006)
10.1182/BLOOD.V100.8.2950
Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.
M. Lim (2002)
10.1074/JBC.M411346200
Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase*
L. Tintignac (2005)
10.1158/1078-0432.CCR-07-1585
Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
T. Fujita (2008)
10.1038/onc.2011.432
F box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest
B. Chen (2012)
10.1095/biolreprod.108.071407
Ubiquitin-Conjugating Enzyme UBE2D2 Is Responsible for FBXW2 (F-Box and WD Repeat Domain Containing 2)-Mediated Human GCM1 (Glial Cell Missing Homolog 1) Ubiquitination and Degradation1
M. Chiang (2008)
10.7314/APJCP.2012.13.11.5725
Deregulated expression of cry1 and cry2 in human gliomas.
Y. Luo (2012)
10.1038/nrd4432
SCF ubiquitin ligase-targeted therapies
J. Skaar (2014)
10.1038/12013
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
A. Carrano (1999)
10.1016/j.bbamcr.2013.06.018
E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
S. Lochab (2013)
10.1128/MCB.06570-11
Genetic Reevaluation of the Role of F-Box Proteins in Cyclin D1 Degradation
T. Kanie (2011)
10.1038/sj.onc.1210971
Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1–S transition
M. S. Song (2008)
10.1101/GAD.1524107
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.
J. Tan (2007)
10.1093/nar/gkt935
Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability
Rosa Viñas-Castells (2014)
10.1074/jbc.M604983200
Phosphorylation and Ubiquitination of the Transcription Factor Sterol Regulatory Element-binding Protein-1 in Response to DNA Binding*
T. Punga (2006)
10.4161/cc.9.5.10916
A comparison between Skp2 and FOXO1 for their cytoplasmic localization by Akt1
H. Wang (2010)
Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.
J. Zhong (2013)
10.1074/jbc.M802160200
A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer Cells*
Shuo Wei (2008)
10.1038/nrm3741
Regulated protein turnover: snapshots of the proteasome in action
S. Bhattacharyya (2014)
10.1038/sj.onc.1206339
SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells
S. Bhattacharya (2003)
10.1038/nrc2396
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
David Frescas (2008)
10.1038/nature06255
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes
David Frescas (2007)
10.3892/IJO.18.5.959
Expression profiles of betaTRCP1 and betaTRCP2, and mutation analysis of betaTRCP2 in gastric cancer.
T. Saitoh (2001)
10.1016/j.molcel.2013.01.016
Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation.
Xudong Wu (2013)
10.1158/0008-5472.CAN-06-1603
Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
Y. Hiramatsu (2006)
10.1172/JCI64535
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
A. Tzatsos (2013)
10.1101/GAD.1574507
Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions.
Han Liu (2007)
10.1016/j.cell.2013.06.048
Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
C. Chan (2013)
10.1128/MCB.00288-12
Fbw7α and Fbw7γ Collaborate To Shuttle Cyclin E1 into the Nucleolus for Multiubiquitylation
N. Bhaskaran (2012)
10.1371/journal.pone.0000128
A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation
H. Okabe (2006)
10.1371/journal.pone.0063610
The Novel Ubiquitin Ligase Complex, SCFFbxw4, Interacts with the COP9 Signalosome in an F-Box Dependent Manner, Is Mutated, Lost and Under-Expressed in Human Cancers
W. Lockwood (2013)
10.1248/BPB.B12-00330
Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
H. Sasajima (2012)
10.1038/nature06641
Control of chromosome stability by the β-TrCP–REST–Mad2 axis
D. Guardavaccaro (2008)
10.1111/j.1600-0463.2007.apm_562.x
Somatic mutations of the β‐TrCP gene in gastric cancer
C. J. Kim (2007)
10.1093/JNCI/DJH219
Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer
A. Ougolkov (2004)
10.1073/PNAS.95.19.11324
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.
Z. Yu (1998)
10.1016/S1534-5807(04)00131-5
Skp2-mediated degradation of p27 regulates progression into mitosis.
K. Nakayama (2004)
10.1073/pnas.1831009100
Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation
T. Kamura (2003)
Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy.
G. G. Xiao (2008)
10.1038/nature08815
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence
Hui-Kuan Lin (2010)
10.1182/blood-2012-02-408492
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Ann-Kathrin Eisfeld (2012)
10.1101/gad.207720.112
The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.
Michael A Davis (2013)
10.1074/jbc.M109.099440
The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs*
Ning Liu (2010)
10.1210/MEND.15.5.0640
Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
D. Waltregny (2001)
10.1242/jcs.068502
Plk4 trans-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation
G. Guderian (2010)
10.1128/MCB.00706-13
The FBXO4 Tumor Suppressor Functions as a Barrier to BrafV600E-Dependent Metastatic Melanoma
E. K. Lee (2013)
10.1016/j.humpath.2008.03.004
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
David Voduc (2008)
10.1002/bies.201100101
The two faces of FBW7 in cancer drug resistance
Z. Wang (2011)
10.1128/MCB.24.6.2487-2498.2004
Cyclin F Disruption Compromises Placental Development and Affects Normal Cell Cycle Execution
M. Tetzlaff (2004)
10.1016/S1534-5807(03)00153-9
Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase.
F. Margottin-Goguet (2003)
10.1007/s13277-014-2104-9
RETRACTED ARTICLE: FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration
Gang Cen (2014)
10.1159/000373988
FBXL5 Inhibits Metastasis of Gastric Cancer Through Suppressing Snail1
Weidong Wu (2015)
10.18632/ONCOTARGET.1151
Regulation of GSK3β-FBXW7-JUNB Axis
B. Pérez-Benavente (2013)
10.1074/jbc.M806487200
Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation*
P. Xie (2009)
10.1158/1078-0432.CCR-12-0873
Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
W. Fiskus (2012)
10.1073/PNAS.0307700101
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.
N. Watanabe (2004)
10.1126/science.1162981
FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression
J. Mao (2008)
10.1074/JBC.M404950200
Fbx7 Functions in the SCF Complex Regulating Cdk1-Cyclin B-phosphorylated Hepatoma Up-regulated Protein (HURP) Proteolysis by a Proline-rich Region*[boxs]
Jung-Mao Hsu (2004)
10.1126/SCIENCE.1141138
The After-Hours Mutant Reveals a Role for Fbxl3 in Determining Mammalian Circadian Period
Sofia I H Godinho (2007)
10.1016/J.BBRC.2006.02.061
The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination.
Yung-Fu Chang (2006)
10.1038/ncb2463
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
L. Busino (2012)



This paper is referenced by
10.1002/pros.23746
β‐TrCP upregulates HIF‐1 in prostate cancer cells
M. Cohen (2019)
10.1186/s13046-018-0736-0
PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma
Y. Yang (2018)
10.1007/978-3-030-38266-7_2
Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer.
P. Gâtel (2020)
10.1038/s41431-018-0292-2
De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms
S. Jansen (2019)
10.5772/INTECHOPEN.70039
Biological Consequences of Priming Phosphorylation in Cancer Development
K. Aoki (2017)
10.1016/j.celrep.2017.08.099
The E3 Ubiquitin Ligase SCF(Cyclin F) Transmits AKT Signaling to the Cell-Cycle Machinery.
Rajarshi Choudhury (2017)
USP7 stabilizes EZH2 and enhances cancer malignant progression.
Nana Zheng (2020)
10.1016/j.canlet.2018.03.042
Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21Cip1/Waf1, p27Kip1 and cyclin D1.
Karnika Singh (2018)
10.1007/s00018-018-2763-6
RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization
G. Tanghe (2018)
10.18632/oncotarget.13153
Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor
Xin Cheng (2017)
10.1016/j.canlet.2019.09.008
Regulation of F-box proteins by noncoding RNAs in human cancers.
Min Lin (2019)
10.1158/1541-7786.MCR-18-0991
The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation
Reyhaneh Salehi-Tabar (2019)
10.1016/j.jmb.2017.02.012
Cullin E3 Ligase Activity Is Required for Myoblast Differentiation.
Jordan Blondelle (2017)
10.2174/1574892812666161123142037
Recent Patents on Proteasome Inhibitors of Natural Origin.
Daniela Correia da Silva (2017)
10.1111/cas.14534
FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis
Yoshikazu Johmura (2020)
10.5772/INTECHOPEN.82874
Ubiquitin Signaling in Regulation of the Start of the Cell Cycle
Michael J. Emanuele (2019)
Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.
J. Su (2016)
10.1016/j.chembiol.2017.06.009
β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling.
Marcus J. C. Long (2017)
10.1101/272500
The tumor suppressor FBW7 and the vitamin D receptor are mutual cofactors
Reyhaneh Salehi-Tabar (2018)
10.1016/j.bbrc.2019.12.050
β-TRCP-mediated AEBP2 ubiquitination and destruction controls cisplatin resistance in ovarian cancer.
Q. Zhang (2019)
10.1016/j.canlet.2020.11.051
Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells.
Manisha Bungsy (2020)
10.1083/jcb.201603062
ASB7 regulates spindle dynamics and genome integrity by targeting DDA3 for proteasomal degradation
Keiji Uematsu (2016)
10.4049/jimmunol.1901142
The SCFβ-TrCP E3 Ubiquitin Ligase Regulates Immune Receptor Signaling by Targeting the Negative Regulatory Protein TIPE2
Yunwei Lou (2020)
10.1111/ajt.15372
WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure
Michael E Seifert (2019)
10.1038/s41419-019-1783-y
F-box protein FBXO30 mediates retinoic acid receptor γ ubiquitination and regulates BMP signaling in neural tube defects
Xiyue Cheng (2019)
10.1016/j.ebiom.2019.11.031
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
Li Zhou (2019)
10.1016/j.omto.2019.01.006
Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells
Jiankun Gao (2019)
Molecular Carcinogenesis
Lu Ren (2019)
10.1080/13543776.2018.1549229
A patent review of the ubiquitin ligase system: 2015–2018
X. Li (2018)
10.18632/oncotarget.21843
FBXW8-dependent degradation of MRFAP1 in anaphase controls mitotic cell death
Duan-zhuo Li (2017)
10.2337/db17-1348
Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A
Jiejie Zhao (2018)
10.1038/s41418-019-0392-8
CSNAP, the smallest CSN subunit, modulates proteostasis through cullin-RING ubiquitin ligases
Maria G. Füzesi-Levi (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar